• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在缺血性中风模型中,异氟烷预处理可抑制组织型纤溶酶原激活剂对脑内皮细胞的作用。

Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an model of ischemic stroke.

作者信息

Cheon So Yeong, Kim So Yeon, Kam Eun Hee, Lee Jae Hoon, Kim Jeong Min, Kim Eun Jung, Kim Tae Whan, Koo Bon-Nyeo

机构信息

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

Int J Med Sci. 2017 Apr 8;14(5):425-433. doi: 10.7150/ijms.18037. eCollection 2017.

DOI:10.7150/ijms.18037
PMID:28539818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5441034/
Abstract

Tissue-type plasminogen activator (tPA) is the only treatment for ischemic stroke. However, tPA could induce the intracranial hemorrhage (ICH), which is the main cause of death in ischemic stroke patient after tPA treatment. At present, there is no treatment strategy to ameliorate tPA-induced brain injury after ischemia. Therefore, we investigated the effect of pre-treated isoflurane, which is a volatile anesthetic and has beneficial effects on neurological dysfunction, brain edema and infarct volume in ischemic stroke model. In this study, we used oxygen/glucose deprivation and reperfusion (OGD/R) condition to mimic an ischemic stroke Matrix metalloproteinases (MMP) activity was measured in endothelial cell media. Also, neuronal cell culture was performed to investigate the effect of pretreated isoflurane on the neuronal cell survival after tPA-induced injury during OGD/R. Isoflurane pretreatment prevented tPA-induced MMP-2 and MMP-9 activity and suppressed tPA-triggered LRP/NF-κB/Cox-2 signaling after OGD/R. Neuronal cells, incubated with endothelial cell conditioned medium (EC-CM) after tPA + OGD/R, showed upregulation of pro-apoptotic molecules. However, neurons incubated with isoflurane-pretreated EC-CM showed increased anti-apoptotic molecules. Our findings suggest that isoflurane pretreatment could attenuate tPA-exaggerated brain ischemic injury, by reducing tPA-induced LRP/NF-κB/Cox-2 in endothelial cells, endothelial MMP-2 and MMP-9 activation, and subsequent pro-apoptotic molecule in neurons after OGD/R.

摘要

组织型纤溶酶原激活剂(tPA)是缺血性中风的唯一治疗方法。然而,tPA可诱发颅内出血(ICH),这是tPA治疗后缺血性中风患者死亡的主要原因。目前,尚无改善缺血后tPA诱导的脑损伤的治疗策略。因此,我们研究了预先使用异氟醚的效果,异氟醚是一种挥发性麻醉剂,对缺血性中风模型中的神经功能障碍、脑水肿和梗死体积具有有益作用。在本研究中,我们使用氧/葡萄糖剥夺和再灌注(OGD/R)条件来模拟缺血性中风。在内皮细胞培养基中测量基质金属蛋白酶(MMP)活性。此外,进行神经元细胞培养以研究预先使用异氟醚对OGD/R期间tPA诱导损伤后神经元细胞存活的影响。异氟醚预处理可预防tPA诱导的MMP-2和MMP-9活性,并在OGD/R后抑制tPA触发的LRP/NF-κB/Cox-2信号传导。在tPA + OGD/R后与内皮细胞条件培养基(EC-CM)孵育的神经元细胞显示促凋亡分子上调。然而,与异氟醚预处理的EC-CM孵育的神经元显示抗凋亡分子增加。我们的研究结果表明,异氟醚预处理可减轻tPA加剧的脑缺血损伤,其机制是通过减少内皮细胞中tPA诱导的LRP/NF-κB/Cox-2、内皮MMP-2和MMP-9激活,以及OGD/R后神经元中随后的促凋亡分子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5441034/1c002b723cf4/ijmsv14p0425g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5441034/40b211b34132/ijmsv14p0425g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5441034/ebc41d61a740/ijmsv14p0425g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5441034/c9c9f1b64424/ijmsv14p0425g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5441034/befa6cb1cb7d/ijmsv14p0425g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5441034/1c002b723cf4/ijmsv14p0425g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5441034/40b211b34132/ijmsv14p0425g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5441034/ebc41d61a740/ijmsv14p0425g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5441034/c9c9f1b64424/ijmsv14p0425g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5441034/befa6cb1cb7d/ijmsv14p0425g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67db/5441034/1c002b723cf4/ijmsv14p0425g005.jpg

相似文献

1
Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an model of ischemic stroke.在缺血性中风模型中,异氟烷预处理可抑制组织型纤溶酶原激活剂对脑内皮细胞的作用。
Int J Med Sci. 2017 Apr 8;14(5):425-433. doi: 10.7150/ijms.18037. eCollection 2017.
2
Isoflurane Postconditioning Inhibits tPA-Induced Matrix Metalloproteinases Activation After Hypoxic Injury via Low-Density Lipoprotein Receptor-Related Protein and Extracellular Signal-Regulated Kinase Pathway.异氟烷后处理通过低密度脂蛋白受体相关蛋白和细胞外信号调节激酶途径抑制缺氧损伤后组织型纤溶酶原激活剂诱导的基质金属蛋白酶激活。
Neurochem Res. 2017 May;42(5):1533-1542. doi: 10.1007/s11064-017-2211-2. Epub 2017 Mar 16.
3
Release of Matrix Metalloproteinases-2 and 9 by S-Nitrosylated Caveolin-1 Contributes to Degradation of Extracellular Matrix in tPA-Treated Hypoxic Endothelial Cells.S-亚硝基化的小窝蛋白-1释放基质金属蛋白酶-2和9有助于组织型纤溶酶原激活剂处理的缺氧内皮细胞中细胞外基质的降解。
PLoS One. 2016 Feb 16;11(2):e0149269. doi: 10.1371/journal.pone.0149269. eCollection 2016.
4
Role of tissue-type plasminogen activator in ischemic stroke.组织型纤溶酶原激活物在缺血性脑卒中的作用。
J Pharmacol Sci. 2010;113(3):203-7. doi: 10.1254/jphs.10r01cp. Epub 2010 Jun 29.
5
Differences in Acute Expression of Matrix Metalloproteinases-9, 3, and 2 Related to the Duration of Brain Ischemia and Tissue Plasminogen Activator Treatment in Experimental Stroke.实验性脑卒中与脑缺血持续时间及组织型纤溶酶原激活剂治疗相关的基质金属蛋白酶-9、3、2 的急性表达差异。
Int J Mol Sci. 2024 Aug 30;25(17):9442. doi: 10.3390/ijms25179442.
6
NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.NURR1与缺血性中风后重组组织型纤溶酶原激活剂治疗并发症的关系。
Stroke. 2015 Feb;46(2):477-84. doi: 10.1161/STROKEAHA.114.006826. Epub 2014 Dec 11.
7
Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.硫化氢减轻实验性中风后组织型纤溶酶原激活剂诱导的脑出血。
Transl Stroke Res. 2016 Jun;7(3):209-19. doi: 10.1007/s12975-016-0459-5. Epub 2016 Mar 28.
8
Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: intracranial bleeding associated with the treatment of ischemic stroke: thrombolytic treatment of ischemia-affected endothelial cells with tissue-type plasminogen activator.脑卒中时内皮损伤的新情况——脑卒中的发病机制与药物研发策略:与缺血性脑卒中治疗相关的颅内出血:组织型纤溶酶原激活物对缺血性内皮细胞的溶栓治疗。
J Pharmacol Sci. 2011;116(1):25-9. doi: 10.1254/jphs.10r27fm. Epub 2011 Apr 16.
9
New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator.实验性缺血性卒中的新溶栓策略:基质金属蛋白酶 10 单独或与组织型纤溶酶原激活剂联合应用。
Cardiovasc Res. 2017 Aug 1;113(10):1219-1229. doi: 10.1093/cvr/cvx069.
10
Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.牛磺酸可减少组织型纤溶酶原激活物(tPA)诱导的栓塞性卒中后大鼠的出血和微血管血栓形成。
Stroke. 2018 Jul;49(7):1708-1718. doi: 10.1161/STROKEAHA.118.020747. Epub 2018 May 29.

引用本文的文献

1
The Role of Matrix Metalloproteinases in Hemorrhagic Transformation in the Treatment of Stroke with Tissue Plasminogen Activator.基质金属蛋白酶在组织型纤溶酶原激活剂治疗中风后出血转化中的作用
J Pers Med. 2023 Jul 23;13(7):1175. doi: 10.3390/jpm13071175.
2
Isoflurane post-conditioning contributes to anti-apoptotic effect after cerebral ischaemia in rats through the ERK5/MEF2D signaling pathway.异氟烷后处理通过 ERK5/MEF2D 信号通路促进大鼠脑缺血后的抗细胞凋亡作用。
J Cell Mol Med. 2021 Apr;25(8):3803-3815. doi: 10.1111/jcmm.16282. Epub 2021 Feb 23.
3
NF-κB and tPA Signaling in Kidney and Other Diseases.

本文引用的文献

1
Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.重组组织型纤溶酶原激活剂通过血管内皮生长因子介导的内皮细胞内吞作用,在小鼠脑缺血期间短暂增强血脑屏障通透性。
J Cereb Blood Flow Metab. 2015 Dec;35(12):2021-31. doi: 10.1038/jcbfm.2015.167. Epub 2015 Jul 29.
2
Effect of isoflurane post-treatment on tPA-exaggerated brain injury in a rat ischemic stroke model.异氟烷后处理对大鼠缺血性脑卒中模型中组织型纤溶酶原激活剂(tPA)所致脑损伤的影响。
Korean J Anesthesiol. 2015 Jun;68(3):281-6. doi: 10.4097/kjae.2015.68.3.281. Epub 2015 May 28.
3
NF-κB 和 tPA 在肾脏和其他疾病中的信号转导作用。
Cells. 2020 May 29;9(6):1348. doi: 10.3390/cells9061348.
4
TGF-β2/Smad3 Signaling Pathway Activation Through Enhancing VEGF and CD34 Ameliorates Cerebral Ischemia/Reperfusion Injury After Isoflurane Post-conditioning in Rats.TGF-β2/Smad3 信号通路的激活通过增强 VEGF 和 CD34 减轻异氟醚后处理大鼠脑缺血/再灌注损伤。
Neurochem Res. 2019 Nov;44(11):2606-2618. doi: 10.1007/s11064-019-02880-8. Epub 2019 Sep 25.
5
Opioids Preconditioning Upon Renal Function and Ischemia-Reperfusion Injury: A Narrative Review.阿片类药物预处理对肾功能和缺血再灌注损伤的影响:叙事性综述。
Medicina (Kaunas). 2019 Aug 23;55(9):522. doi: 10.3390/medicina55090522.
6
TGF-β2 Induces Gli1 in a Smad3-Dependent Manner Against Cerebral Ischemia/Reperfusion Injury After Isoflurane Post-conditioning in Rats.在大鼠异氟烷后处理后,转化生长因子-β2以Smad3依赖的方式诱导Gli1,对抗脑缺血/再灌注损伤。
Front Neurosci. 2019 Jun 26;13:636. doi: 10.3389/fnins.2019.00636. eCollection 2019.
7
Isoflurane Post-conditioning Ameliorates Cerebral Ischemia/Reperfusion Injury by Enhancing Angiogenesis Through Activating the Shh/Gli Signaling Pathway in Rats.异氟烷后处理通过激活大鼠Shh/Gli信号通路增强血管生成来减轻脑缺血/再灌注损伤。
Front Neurosci. 2019 Apr 9;13:321. doi: 10.3389/fnins.2019.00321. eCollection 2019.
8
Developing a standardized system of exposure and intervention endpoints for isoflurane in preclinical stroke models.为临床前卒中模型中的异氟烷开发标准化的暴露和干预终点系统。
Med Gas Res. 2019 Jan-Mar;9(1):46-51. doi: 10.4103/2045-9912.254640.
9
Isoflurane Preconditioning Attenuates Brain Injury Induced by Electromagnetic Pulse via the TLR4/NFB Signaling Pathway.异氟烷预处理通过 TLR4/NFB 信号通路减轻电磁脉冲诱导的脑损伤。
Oxid Med Cell Longev. 2019 Jan 6;2019:9653494. doi: 10.1155/2019/9653494. eCollection 2019.
10
Saponins Protect Cerebral Microvascular Endothelial Cells against Oxygen-Glucose Deprivation/Reperfusion-Induced Barrier Dysfunction via Activation of PI3K/Akt/Nrf2 Antioxidant Signaling Pathway.皂苷通过激活 PI3K/Akt/Nrf2 抗氧化信号通路保护脑微血管内皮细胞免受氧葡萄糖剥夺/再灌注诱导的屏障功能障碍。
Molecules. 2018 Oct 26;23(11):2781. doi: 10.3390/molecules23112781.
Protective role of isoflurane pretreatment in rats with focal cerebral ischemia and the underlying molecular mechanism.
异氟烷预处理对局灶性脑缺血大鼠的保护作用及其潜在分子机制
Mol Med Rep. 2015 Jul;12(1):675-83. doi: 10.3892/mmr.2015.3408. Epub 2015 Mar 4.
4
Effects of isoflurane postconditioning on chronic phase of ischemia-reperfusion heart injury in rats.异氟烷预处理对大鼠缺血再灌注心脏损伤慢性期的影响。
Cardiovasc Pathol. 2015 Mar-Apr;24(2):94-101. doi: 10.1016/j.carpath.2014.09.004. Epub 2014 Sep 16.
5
Isoflurane reduces the ischemia reperfusion injury surge: a longitudinal study with MRI.异氟烷可减轻缺血再灌注损伤高峰:一项MRI纵向研究
Brain Res. 2014 Oct 24;1586:173-83. doi: 10.1016/j.brainres.2014.08.003. Epub 2014 Aug 12.
6
Isoflurane preconditioning ameliorates renal ischemia-reperfusion injury through antiinflammatory and antiapoptotic actions in rats.异氟醚预处理通过抗炎和抗凋亡作用减轻大鼠肾缺血再灌注损伤。
Biol Pharm Bull. 2014;37(10):1599-605. doi: 10.1248/bpb.b14-00211. Epub 2014 Aug 2.
7
Isoflurane on brain inflammation.异氟烷对脑炎症的影响。
Neurobiol Dis. 2014 Feb;62:365-71. doi: 10.1016/j.nbd.2013.09.016. Epub 2013 Sep 29.
8
Sevoflurane and isoflurane preconditioning provides neuroprotection by inhibition of apoptosis-related mRNA expression in a rat model of focal cerebral ischemia.七氟醚和异氟醚预处理通过抑制局灶性脑缺血大鼠模型中凋亡相关 mRNA 表达提供神经保护作用。
J Neurosurg Anesthesiol. 2012 Oct;24(4):336-44. doi: 10.1097/ANA.0b013e318266791e.
9
Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.重组组织型纤溶酶原激活剂在短暂性局灶性脑缺血后通过基质金属蛋白酶-9 非依赖性途径诱导血脑屏障破裂。
Eur J Neurosci. 2011 Oct;34(7):1085-92. doi: 10.1111/j.1460-9568.2011.07843.x. Epub 2011 Sep 6.
10
Recombinant tissue plasminogen activator increases blood-brain barrier disruption in acute ischemic stroke: an MR imaging permeability study.重组组织型纤溶酶原激活剂增加急性缺血性脑卒中的血脑屏障破坏:磁共振成像渗透性研究。
AJNR Am J Neuroradiol. 2009 Nov;30(10):1864-9. doi: 10.3174/ajnr.A1774. Epub 2009 Aug 6.